Three-year clinical outcomes of a fractional flow reserve-guided percutaneous coronary intervention (PCI) strategy: A comparison of nicorandil and ATP
Background: Nicorandil is used to induce hyperemia when measuring fractional flow reserve (FFR). However, it is unknown whether the clinical outcome of patients assessed using nicorandil is similar to that of patients assessed using adenosine triphosphatase (ATP). We aimed to compare the clinical ou...
Saved in:
| Main Authors: | Yuki Numajiri, Daisuke Wada, Yuki Ishii, Yuka Tanizaki, Yosuke Takei, Hiromoto Sone, Kazuma Tashiro, Takuya Mizukami, Tokutada Sato, Takaaki Matsuyama, Hiroshi Suzuki, Hiroyoshi Mori |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | International Journal of Cardiology: Heart & Vasculature |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352906725001113 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION
by: Z. M. Sizova, et al.
Published: (2016-01-01) -
Beyond the Usual: Unmasking Nicorandil’s Hidden Side – A Case of Colonic Ulceration
by: Urvashi Khan
Published: (2024-10-01) -
Nicorandil in the prevention of cardiac damage and type 4A myocardial infarction with planned percutaneous coronary intervention in patients with atherosclerosis of coronary arteries
by: G. N. Soboleva, et al.
Published: (2019-06-01) -
The Safety of Nicorandil Therapy and the Relationship with Treatment Adherence in Patients with Stable Angina Pectoris (According to the NIKEA Observational Study)
by: Yu. V. Lukina, et al.
Published: (2022-09-01) -
ASSESSMENT OF ADHERENCE TO TREATMENT AND FACTORS AFFECTING IT IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DURING THERAPY WITH NICORANDIL
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)